Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure

ClinicalTrials.gov ID: NCT01644331

Public ClinicalTrials.gov record NCT01644331. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 6:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The Targeting Acute Congestion With Tolvaptan In Congestive Heart Failure Study

Study identification

NCT ID
NCT01644331
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Duke University
Other
Enrollment
257 participants

Conditions and interventions

Interventions

  • Tolvaptan Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2012
Primary completion
Jan 31, 2016
Completion
Jan 31, 2016
Last update posted
Apr 26, 2017

2012 – 2016

United States locations

U.S. sites
18
U.S. states
11
U.S. cities
17
Facility City State ZIP Site status
University of Colorado at Denver and Health Sciences Center Aurora Colorado 80045
Emory University School of Medicine Atlanta Georgia 30322
Northeast Georgia Heart Center Gainesville Georgia 30501
Mercer University School of Medicine Macon Georgia 31201
University of Chicago Chicago Illinois 60637
Indiana University School of Medicine Indianapolis Indiana 46202
Hennepin County Medical Center Minneapolis Minnesota 55415
Montefiore Medical Center The Bronx New York 10461
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599
Novant Health Heart and Vascular Charlotte North Carolina 28204
Duke University Medical Center Durham North Carolina 27713
Southeastern Regional Medical Center Lumberton North Carolina 28358
The Christ Hospital Cincinnati Ohio 45219
University of Cincinnati Medical Center Cincinnati Ohio 45267
Allegheny Valley Hospital Natrona Heights Pennsylvania 15065
Grand View - Lehigh Valley Health Services Sellersville Pennsylvania 18960
UT Southwestern Medical center Dallas Texas 75390
Inova Heart and Vascular Institute Falls Church Virginia 22042

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01644331, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 26, 2017 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01644331 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →